Clinical benefit of treatment with eribulin mesylate for metastatic triple-negative breast cancer: Long-term outcomes of patients treated in the US community oncology setting.
| Image |  |
|---|---|
| Description | scientific article published on 31 July 2018 |
| Author/s |
author: Sarah S Mougalian |
| Publication date | July 31, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |